Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma

[1] Allgar VL(2005)Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer Br J Cancer 92 1959-1970

[2] Neal RD(2012)Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets Br J Cancer 107 1220-1226

[3] Elliss-Brookes L(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2893-2917

[4] McPhail S(2014)Risk factors for delay in symptomatic presentation: a survey of cancer patients Br J Cancer 111 581-588

[5] Ives A(2011)Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia Cancer 117 1470-1477

[6] Greenslade M(2011)Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients BMC Health Serv Res 11 284-278

[7] Shelton J(2013)Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network BMC Hematol 13 9-532

[8] Hiom S(2006)Lymphoma: variations in time to diagnosis and treatment Eur J Cancer Care (Engl) 15 272-403

[9] Richards M(2007)Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma Eur J Cancer Care (Engl) 16 529-594

[10] Ferlay J(2008)Help-seeking behaviour in patients with lymphoma Eur J Cancer Care (Engl) 17 394-96

[1] Allgar VL(2005)Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer Br J Cancer 92 1959-1970

[2] Neal RD(2012)Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets Br J Cancer 107 1220-1226

[3] Elliss-Brookes L(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2893-2917

[4] McPhail S(2014)Risk factors for delay in symptomatic presentation: a survey of cancer patients Br J Cancer 111 581-588

[5] Ives A(2011)Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia Cancer 117 1470-1477

[6] Greenslade M(2011)Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients BMC Health Serv Res 11 284-278

[7] Shelton J(2013)Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network BMC Hematol 13 9-532

[8] Hiom S(2006)Lymphoma: variations in time to diagnosis and treatment Eur J Cancer Care (Engl) 15 272-403

[9] Richards M(2007)Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma Eur J Cancer Care (Engl) 16 529-594

[10] Ferlay J(2008)Help-seeking behaviour in patients with lymphoma Eur J Cancer Care (Engl) 17 394-96